These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17996583)

  • 1. Pharmacogenetics of the beta 2-adrenergic receptor gene.
    Ortega VE; Hawkins GA; Peters SP; Bleecker ER
    Immunol Allergy Clin North Am; 2007 Nov; 27(4):665-84; vii. PubMed ID: 17996583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
    Ortega VE; Meyers DA
    J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
    Ortega VE
    Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical consequences of ADRbeta2 polymorphisms.
    Hawkins GA; Weiss ST; Bleecker ER
    Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
    Metzger NL; Kockler DR; Gravatt LA
    Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of β2-agonists.
    Hizawa N
    Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
    Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-receptor polymorphisms in asthma.
    Kelly HW
    Lancet; 2009 Nov; 374(9703):1726-8. PubMed ID: 19932345
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
    Lipworth BJ; Dempsey OJ; Aziz I; Wilson AM
    Am J Med; 2000 Aug; 109(2):114-21. PubMed ID: 10967152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
    Slankard M; Michelis MA; Mansukhani M; McGoey B; Paige A; Andrews H; Lederer D; Canfield S; DiMango E
    J Asthma; 2016 Oct; 53(8):783-9. PubMed ID: 27050801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.
    Tantisira KG; Small KM; Litonjua AA; Weiss ST; Liggett SB
    Hum Mol Genet; 2005 Jun; 14(12):1671-7. PubMed ID: 15879435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
    Hancox RJ; Sears MR; Taylor DR
    Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
    Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
    Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.